Suru Chemicals And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 4.62 M
as on 04-07-2024
- Company Age 49 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.43 Cr
as on 04-07-2024
- Revenue -36.43%
(FY 2023)
- Profit -82.94%
(FY 2023)
- Ebitda -79.06%
(FY 2023)
- Net Worth 2.85%
(FY 2023)
- Total Assets 14.78%
(FY 2023)
About Suru Chemicals And Pharmaceuticals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.62 M.
The company currently has active open charges totaling ₹10.43 Cr.
Surekha Shah, Hitesh Shah, Viraj Shah, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24110MH1975PTC018178
- Company No.
018178
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 1975
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Suru Chemicals And Pharmaceuticals Private Limited offer?
Suru Chemicals And Pharmaceuticals Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Body Care Products, Anhydrous Lanolin, Lanolin, Industrial Acid, Fatty Acid, Acetylated Lanolin Alcohol.
Who are the key members and board of directors at Suru Chemicals And Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jashvant Shah  | Managing Director | 18-Mar-1975 | Current |
| Surekha Shah | Managing Director | 18-Mar-1975 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Viraj Shah | Director | 19-Jun-2018 | Current |
| Dimple Shah | Director | 19-Jun-2018 | Current |
| Hitesh Shah | Director | 01-Jul-1988 | Current |
Financial Performance of Suru Chemicals And Pharmaceuticals.
Suru Chemicals And Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.43% decrease. The company also saw a substantial fall in profitability, with a 82.94% decrease in profit. The company's net worth moved up by a moderate rise of 2.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suru Chemicals And Pharmaceuticals?
In 2022, Suru Chemicals And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dena Bank Creation Date: 13 Mar 2014 | ₹0.43 M | Open |
Dena Bank Creation Date: 03 Nov 2004 | ₹6.03 Cr | Open |
Dena Bank Creation Date: 11 Sep 2003 | ₹0.70 M | Open |
How Many Employees Work at Suru Chemicals And Pharmaceuticals?
Unlock and access historical data on people associated with Suru Chemicals And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suru Chemicals And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suru Chemicals And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
